Article Details
Retrieved on: 2024-07-14 16:18:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article provides an overview of advancements in the treatment of bladder cancer, particularly focusing on urothelial carcinoma. It highlights the role of epidemiology in understanding cancer prevalence and mortality rates and discusses the evolution of therapies, including orphan and antineoplastic drugs, checkpoint inhibitors, and novel agents like pembrolizumab, atezolizumab, and enfortumab vedotin. The insights are particularly relevant under the key concept of epidemiology and related tags.
Article found on: www.pharmacytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here